Stocktoria

Faeth Therapeutics, Inc. FTH

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-02-04

Faeth Therapeutics, Inc. statistics & valuation

Market cap$19.5M
P / B1.0×
Return on equity-113.4%
Return on capital-119.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-25.10% -47.00% -52.50% -78.60% -113.40% 202020212022202320242025
Shares outstanding
1.9M 30.6M 30.8M 28.0M 1.3M 1.3M 202020212022202320242025
Net debt ($)
-$16.0M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-93.80% -24.00% -41.00% -45.90% -66.50% -92.10% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$1.33 -$1.58 -$1.22 -$24.01 -$16.72 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-92.1%-66.5%-45.9%-41.0%-24.0%-93.8%
Return on equity-113.4%-78.6%-52.5%-47.0%-25.1%35.6%
Debt / equity—————-0.01×
Current ratio5.067.7011.9211.9830.384.16

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.